Position in DYN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$3,394,352
-$29,039 QoQ
Shares Held
187,223
+7.0% QoQ
Ownership
0.131%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 27.482734493091126.ToString("F0")%
Shared 0.ToString("F0")%
None 72.51726550690887.ToString("F0")%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,238,262,141 across 282 Biotechnology names. DYN ranks #59 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in DYN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,394,352 | 187,223 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,423,391 | 175,020 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,122,923 | 167,820 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,471,230 | 154,541 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,397,738 | 133,627 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $3,021,428 | 128,244 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $4,472,399 | 124,510 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $4,291,087 | 121,595 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,791,560 | 98,329 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,013,965 | 76,238 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $632,316 | 70,571 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $719,010 | 63,912 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $589,593 | 51,180 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $570,390 | 49,214 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $619,988 | 48,818 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $304,904 | 44,382 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $360,960 | 37,444 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $453,068 | 38,105 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $623,453 | 38,390 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $778,269 | 36,990 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $179,340 | 11,548 | Shares | Sole | 2021-05-06 | |
| No filing history on record for this holder in this stock. | ||||||